Annual Total Assets
$5.87 M
-$21.29 M-78.38%
July 31, 2024
Summary
- As of February 7, 2025, BCTX annual total assets is $5.87 million, with the most recent change of -$21.29 million (-78.38%) on July 31, 2024.
- During the last 3 years, BCTX annual total assets has fallen by -$52.17 million (-89.88%).
- BCTX annual total assets is now -89.88% below its all-time high of $58.04 million, reached on July 31, 2021.
Performance
BCTX Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$10.41 M
+$4.54 M+77.35%
October 31, 2024
Summary
- As of February 7, 2025, BCTX quarterly total assets is $10.41 million, with the most recent change of +$4.54 million (+77.35%) on October 31, 2024.
- Over the past year, BCTX quarterly total assets has increased by +$4.21 million (+67.88%).
- BCTX quarterly total assets is now -82.06% below its all-time high of $58.04 million, reached on July 31, 2021.
Performance
BCTX Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
BCTX Total Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -78.4% | +67.9% |
3 y3 years | -89.9% | -78.5% |
5 y5 years | +1220.5% | -78.5% |
BCTX Total Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -89.9% | at low | -78.5% | +77.3% |
5 y | 5-year | -89.9% | +1220.5% | -82.1% | +2268.0% |
alltime | all time | -89.9% | >+9999.0% | -82.1% | >+9999.0% |
BriaCell Therapeutics Total Assets History
Date | Annual | Quarterly |
---|---|---|
Oct 2024 | - | $10.41 M(+77.3%) |
Jul 2024 | $5.87 M(-78.4%) | $5.87 M(-5.3%) |
Apr 2024 | - | $6.20 M(-49.3%) |
Jan 2024 | - | $12.23 M(-34.3%) |
Oct 2023 | - | $18.62 M(-31.5%) |
Jul 2023 | $27.16 M(-36.2%) | $27.16 M(-8.6%) |
Apr 2023 | - | $29.72 M(-13.0%) |
Jan 2023 | - | $34.16 M(-11.2%) |
Oct 2022 | - | $38.45 M(-9.7%) |
Jul 2022 | $42.58 M(-26.6%) | $42.58 M(-8.4%) |
Apr 2022 | - | $46.46 M(-4.3%) |
Jan 2022 | - | $48.55 M(-13.5%) |
Oct 2021 | - | $56.16 M(-3.2%) |
Jul 2021 | $58.04 M(>+9900.0%) | $58.04 M(+175.8%) |
Apr 2021 | - | $21.05 M(+4500.8%) |
Jan 2021 | - | $457.50 K(+1.0%) |
Oct 2020 | - | $452.90 K(-13.3%) |
Jul 2020 | $522.30 K(+17.4%) | $522.30 K(+18.8%) |
Apr 2020 | - | $439.80 K(-8.0%) |
Jan 2020 | - | $478.10 K(+0.4%) |
Oct 2019 | - | $476.40 K(+7.1%) |
Jul 2019 | $444.70 K(-80.5%) | $444.70 K(-62.9%) |
Apr 2019 | - | $1.20 M(+27.9%) |
Jan 2019 | - | $937.70 K(-33.3%) |
Oct 2018 | - | $1.41 M(-38.4%) |
Jul 2018 | $2.29 M(+39.7%) | $2.29 M(-38.4%) |
Apr 2018 | - | $3.71 M(+365.4%) |
Jan 2018 | - | $796.90 K(-39.5%) |
Oct 2017 | - | $1.32 M(-19.5%) |
Jul 2017 | $1.64 M(+95.8%) | $1.64 M(+2.8%) |
Apr 2017 | - | $1.59 M(+16.2%) |
Jan 2017 | - | $1.37 M(-16.8%) |
Oct 2016 | - | $1.65 M(+97.0%) |
Jul 2016 | $835.70 K(-34.5%) | $835.70 K(-31.1%) |
Apr 2016 | - | $1.21 M(+101.2%) |
Jan 2016 | - | $602.90 K(-38.4%) |
Oct 2015 | - | $978.50 K(-23.3%) |
Date | Annual | Quarterly |
---|---|---|
Jul 2015 | $1.28 M(+5239.7%) | $1.28 M(-23.5%) |
Apr 2015 | - | $1.67 M(-5.7%) |
Jan 2015 | - | $1.77 M(-34.4%) |
Oct 2014 | - | $2.69 M(>+9900.0%) |
Jul 2014 | $23.90 K(-99.7%) | $23.90 K(-99.7%) |
Apr 2014 | - | $8.16 M(-4.5%) |
Jan 2014 | - | $8.55 M(-6.8%) |
Oct 2013 | - | $9.17 M(-2.5%) |
Jul 2013 | $9.41 M(-8.8%) | $9.41 M(-2.6%) |
Apr 2013 | - | $9.66 M(-2.1%) |
Jan 2013 | - | $9.86 M(-2.1%) |
Oct 2012 | - | $10.07 M(-2.4%) |
Jul 2012 | $10.32 M(-16.4%) | $10.32 M(-4.8%) |
Apr 2012 | - | $10.84 M(-1.2%) |
Jan 2012 | - | $10.97 M(-3.6%) |
Oct 2011 | - | $11.37 M(-7.9%) |
Jul 2011 | $12.35 M(+738.5%) | $12.35 M(+1.5%) |
Apr 2011 | - | $12.16 M(+825.7%) |
Jan 2011 | - | $1.31 M(-10.9%) |
Oct 2010 | - | $1.47 M(+0.1%) |
Jul 2010 | $1.47 M(+41.7%) | $1.47 M(-21.3%) |
Apr 2010 | - | $1.87 M(+111.1%) |
Jan 2010 | - | $886.00 K(-6.0%) |
Oct 2009 | - | $942.60 K(-9.3%) |
Jul 2009 | $1.04 M(+172.8%) | $1.04 M(+129.4%) |
Apr 2009 | - | $452.80 K(+92.8%) |
Jan 2009 | - | $234.80 K(-12.1%) |
Oct 2008 | - | $267.20 K(-29.8%) |
Jul 2008 | $380.80 K(-16.5%) | $380.80 K(-11.3%) |
Apr 2008 | - | $429.50 K(-6.2%) |
Jan 2008 | - | $457.90 K(-10.1%) |
Oct 2007 | - | $509.30 K(+11.6%) |
Jul 2007 | $456.30 K(+373.3%) | $456.30 K(-1.5%) |
Apr 2007 | - | $463.40 K(+4.9%) |
Jan 2007 | - | $441.90 K(-8.1%) |
Oct 2006 | - | $480.80 K |
Jul 2006 | $96.40 K | - |
FAQ
- What is BriaCell Therapeutics annual total assets?
- What is the all time high annual total assets for BriaCell Therapeutics?
- What is BriaCell Therapeutics annual total assets year-on-year change?
- What is BriaCell Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for BriaCell Therapeutics?
- What is BriaCell Therapeutics quarterly total assets year-on-year change?
What is BriaCell Therapeutics annual total assets?
The current annual total assets of BCTX is $5.87 M
What is the all time high annual total assets for BriaCell Therapeutics?
BriaCell Therapeutics all-time high annual total assets is $58.04 M
What is BriaCell Therapeutics annual total assets year-on-year change?
Over the past year, BCTX annual total assets has changed by -$21.29 M (-78.38%)
What is BriaCell Therapeutics quarterly total assets?
The current quarterly total assets of BCTX is $10.41 M
What is the all time high quarterly total assets for BriaCell Therapeutics?
BriaCell Therapeutics all-time high quarterly total assets is $58.04 M
What is BriaCell Therapeutics quarterly total assets year-on-year change?
Over the past year, BCTX quarterly total assets has changed by +$4.21 M (+67.88%)